Maryland-based Cytomedix secures a $35 million investment commitment from Deerfield Management Co. following an important reimbursement win from the Centers for Medicare & Medicaid Services.
Wound care therapies maker Cytomedix(OTC:CMXI) landed a $35 million investment commitment from Deerfield Management Co., to be handed down in 2 tranches.
Here's a look at some of the top personnel stories for medical device companies this week.
Indianapolis Governor Mike Pence (R) says the 2.3% medical device tax threatens some 20,000 medical device jobs in the Hoosier state.
MASSDEVICE ON CALL — Indianapolis Governor Mike Pence (R) issued a formal letter to the White House yesterday, asking President Barack Obama to repeal the 2.3% medical device tax created in the Affordable Care Act.
Pence asked for President Obama's support in "working with the Congress to repeal the medical device tax entirely," saying that the levy threatens 20,000 direct jobs and 55,000 total that rely on the medtech industry in Indiana alone.
Intuitive Surgical's 4th-generation da Vinci Xi system provides new maneuverability that allows surgeons to tackle more complex procedures and surgeries on multiple sites.
Boston Scientific's subcutaneous implantable cardioverter defibrillator proves safe and effective in the 1st real-world data from the EFFORTLESS S-ICD clinical trial.
Here's a look at some of the top regulatory stories for medical device companies this week.
Medical device makers say they're worried that new regulations in the European Union will slow approvals.
MASSDEVICE ON CALL — Medical device makers that relocated to Europe to take advantage of its easier path to approval are worried about new European Union rules, the Financial Times reports.
Companies such as Middle Peak Medical, which is developing a mitral valve implant, moved some of their operations to the EU to escape the FDA's more-stringent approval protocols. But the new EU rules could take a bite out of that advantage, they worry.
